CLDN6 was also found to play a role in cancer cell migration and invasion in breast cancer (Song et al., 2019), hepatocellular carcinoma (Lu et al., 2021), and gastric cancer (Yu et al., 2019). Here, CLDN6 is linked to breast carcinoma.